Company intelligence / Profile preview
Revive Therapeutics
Toronto, Canadarevivethera.com ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Preclinical
01
Overview
A specialty life sciences company developing therapeutics for infectious diseases, medical countermeasures, and rare disorders through multiple clinical/preclinical programs including Bucillamine repurposing and psychedelic-based therapies.
- Therapeutic areas
- PsychiatryNeurologyInfectious Diseases
- Modalities
- Small molecules(Psychedelic compounds)(Molecular hydrogen)
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Defence Research & Development Canada (nerve agent research)[1][2]
Beyond the preview
Go deeper on Revive Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Revive Therapeutics.